MicroRNAs shown to improve hyperglycemia

January 20, 2017

A study by Tokohu University researchers has identified two new types of microRNA (miRNA) that improved hyperglycemia in a mouse model of diabetes by stimulating the proliferation of insulin-producing pancreatic beta (β) cells. This is a key finding that may lead to the development of new diabetes treatment strategies.

First discovered in the 1990s, miRNAs are small, non-coding RNA molecules that help control cellular processes such as differentiation, proliferation and death. As such, they are potential targets for new treatments for diseases including hepatitis C, cancer and possibly diabetes.

Diabetes is a major cause of blindness, kidney disease, heart attack, stroke, and limb amputation. The World Health Organization projects that diabetes will be the world's seventh leading cause of mortality by 2030, either directly or due to high blood sugar levels.

Diabetes is caused when pancreatic β-cells, which produce the hormone insulin to regulate blood sugar levels, are destroyed by the immune system (type 1 diabetes), or are unable to produce sufficient insulin for adequate glucose control (type 2 diabetes mellitus [T2DM]).

The main treatment goal in T2DM is to restore normal glucose metabolism, ideally by diet, exercise and weight loss. Patients who do not respond to lifestyle modifications are usually placed on oral hypoglycemic drugs, but may eventually need insulin therapy.

This management approach is increasingly complex and expensive, and may cause potentially fatal adverse events, particularly hypoglycemia. Because diabetes symptoms only appear when β-cell numbers become inadequate, regeneration of these cells represents a promising treatment strategy.

Bone marrow (BM) transplantation has been shown to promote β-cell proliferation via BM cell to β-cell intercellular communication. However, the molecular mechanisms underlying β-cell regeneration after transplantation are unknown.

Now Tohoku University researchers have identified two new microRNAs contributing to BM transplantation-induced β-cell regeneration. The team reported it findings online on December 7, 2016, in EBioMedicine.

Following BM transplantation, screening for mouse miRNAs in serum exosomes (lipid vesicles in which miRNAs are transported) revealed that levels of 42 miRNAs were increased.

Two of these miRNAs, miR-106b-5p and miR-222-3p, were shown to be secreted by BM cells and their levels were increased in the pancreatic islet cells that produce insulin. Treatment with anti-miRNAs specific for these miRNAs inhibited BM transplantation-induced β-cell regeneration, confirming their role in this process.

The Tokohu University researchers also demonstrated that administration of corresponding 'miRNA mimics', RNA molecules designed to mimic endogenous mature miRNA molecules, promoted β-cell proliferation after their experimental injury, thereby improving hyperglycemia in a mouse model of insulin-deficient diabetes.

The identification of these two new miRNAs may enable therapeutic β-cell regeneration, therefore having "major potential in the development of regenerative therapies for diabetes mellitus," the researchers conclude.
-end-


Tohoku University

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.